Cargando…

Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents

A 70-year-old man with malignant lymphoma was subjected to a fourth course of chemotherapy using gemcitabine and cisplatin. During the intravenous infusion of anticancer agents, pain and redness was observed at the site of insertion. The patient was subsequently treated with the strongest topical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuda, Hiroto, Masatsugu, Asako, Sijimaya, Takako, Arai, Rie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874355/
https://www.ncbi.nlm.nih.gov/pubmed/29093414
http://dx.doi.org/10.2169/internalmedicine.9329-17
_version_ 1783310150039240704
author Okuda, Hiroto
Masatsugu, Asako
Sijimaya, Takako
Arai, Rie
author_facet Okuda, Hiroto
Masatsugu, Asako
Sijimaya, Takako
Arai, Rie
author_sort Okuda, Hiroto
collection PubMed
description A 70-year-old man with malignant lymphoma was subjected to a fourth course of chemotherapy using gemcitabine and cisplatin. During the intravenous infusion of anticancer agents, pain and redness was observed at the site of insertion. The patient was subsequently treated with the strongest topical steroids and topical cooling agents. However, 2 weeks later, the affected area turned yellow, and the histopathological findings revealed skin necrosis of the entire dermis layer. It took two and a half months to cure the lesion. Close attention should be paid to the development of skin necrosis even when irritant anticancer agents such as gemcitabine and cisplatin are administered.
format Online
Article
Text
id pubmed-5874355
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-58743552018-03-29 Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents Okuda, Hiroto Masatsugu, Asako Sijimaya, Takako Arai, Rie Intern Med Case Report A 70-year-old man with malignant lymphoma was subjected to a fourth course of chemotherapy using gemcitabine and cisplatin. During the intravenous infusion of anticancer agents, pain and redness was observed at the site of insertion. The patient was subsequently treated with the strongest topical steroids and topical cooling agents. However, 2 weeks later, the affected area turned yellow, and the histopathological findings revealed skin necrosis of the entire dermis layer. It took two and a half months to cure the lesion. Close attention should be paid to the development of skin necrosis even when irritant anticancer agents such as gemcitabine and cisplatin are administered. The Japanese Society of Internal Medicine 2017-11-01 2018-03-01 /pmc/articles/PMC5874355/ /pubmed/29093414 http://dx.doi.org/10.2169/internalmedicine.9329-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Okuda, Hiroto
Masatsugu, Asako
Sijimaya, Takako
Arai, Rie
Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents
title Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents
title_full Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents
title_fullStr Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents
title_full_unstemmed Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents
title_short Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents
title_sort skin necrosis due to the extravasation of irritant anticancer agents
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874355/
https://www.ncbi.nlm.nih.gov/pubmed/29093414
http://dx.doi.org/10.2169/internalmedicine.9329-17
work_keys_str_mv AT okudahiroto skinnecrosisduetotheextravasationofirritantanticanceragents
AT masatsuguasako skinnecrosisduetotheextravasationofirritantanticanceragents
AT sijimayatakako skinnecrosisduetotheextravasationofirritantanticanceragents
AT arairie skinnecrosisduetotheextravasationofirritantanticanceragents